GVK Biosciences, a drug discovery R&D organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities. The GLP-compliant facility has equipment to meet the requirements for drug discovery and development, agro and veterinary chemicals, cosmetics, and specialty studies.   Manni Kantipudi, chief executive officer, GVK Biosciences, said, “Several of our customers requested us to extend our chemistry services ...